Tilray Shares Surge on Political Buzz and European Growth

Strategic Moves in Europe Complement Political Catalyst

Tilray shares experienced a substantial upward move this week, climbing approximately 40% by Thursday. This significant appreciation was primarily ignited by a social media post from former President Donald Trump that appeared to endorse CBD products for older adults. Concurrently, the company’s strategic expansion within the German medical cannabis market provided additional positive momentum for the stock.

Amid the market excitement, Tilray announced concrete operational progress in Europe on Tuesday. The company is broadening its medical cannabis offerings in Germany with the introduction of five new premium cannabis flower products. These will be cultivated at its EU-GMP-certified facility located in Neumünster, reinforcing its commitment to quality and local production.